Eyes on $BLU

Bellus Health got a massive gap which droves the the company back into the penniestock level May this year. Still no buyers interests appear for KIACTA™. But as we saw yesterday on Navidea prices there're more examples on the market which show Investors the opposite hidden interests in good studies to buy for producing.